UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Distal femoral fractures

Injury, 2015-06, Vol.46 (6), p.1084-1088

2015

Volltextzugriff (PDF)

Current concepts in the diagnosis and management of extra-articular hip impingement syndromes

International orthopaedics, 2017-07, Vol.41 (7), p.1321-1328

2017

Volltextzugriff (PDF)

Surgical controversies and current concepts in Lisfranc injuries

British medical bulletin, 2022-12, Vol.144 (1), p.57-75

2022

Volltextzugriff (PDF)

A propofol binding site on mammalian GABAA receptors identified by photolabeling

Nature chemical biology, 2013-11, Vol.9 (11), p.715

2013

Volltextzugriff (PDF)

Infant Feeding Practices in a Multi-Ethnic Asian Cohort: The GUSTO Study

Nutrients, 2016-05, Vol.8 (5), p.293-293

2016

Volltextzugriff (PDF)

Locating Binding Sites of the General Anaesthetic Propofol Using Photoaffinity Labelling

Yip, Grace Mei Shan

2013

Volltextzugriff (PDF)

Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles

PloS one, 2015-10, Vol.10 (10), p.e0140842

2015

Volltextzugriff (PDF)

An Aging Population of Chronic Hepatitis B With Increasing Comorbidities: A Territory‐Wide Study From 2000 to 2017

Hepatology (Baltimore, Md.), 2020-02, Vol.71 (2), p.444-455

2020

Volltextzugriff (PDF)

Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatment

Alimentary pharmacology & therapeutics, 2018-11, Vol.48 (9), p.984-992

2018

Volltextzugriff (PDF)

Angiotensin‐converting enzyme inhibitors prevent liver‐related events in nonalcoholic fatty liver disease

Hepatology (Baltimore, Md.), 2022-08, Vol.76 (2), p.469-482

2022

Volltextzugriff (PDF)

Geographical similarity and differences in the burden and genetic predisposition of NAFLD

Hepatology (Baltimore, Md.), 2023-04, Vol.77 (4), p.1404-n/a

2023

Volltextzugriff (PDF)

Liver stiffness measurement predicts long‐term survival and complications in non‐alcoholic fatty liver disease

Liver international, 2020-03, Vol.40 (3), p.581-589

2020

Volltextzugriff (PDF)

Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection

Alimentary pharmacology & therapeutics, 2023-10, Vol.58 (8), p.814-823

2023

Volltextzugriff (PDF)

The safety of stopping nucleos(t)ide analogue treatment in patients with HBeAg‐negative chronic hepatitis B

Liver international, 2020-03, Vol.40 (3), p.549-557

2020

Volltextzugriff (PDF)

Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B? Authors’ reply

Alimentary pharmacology & therapeutics, 2020-01, Vol.51 (2), p.315-316

2020

Volltextzugriff (PDF)

Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patients

Journal of gastroenterology, 2020-09, Vol.55 (9), p.899-908

2020

Volltextzugriff (PDF)

Elevated testosterone increases risk of hepatocellular carcinoma in men with chronic hepatitis B and diabetes mellitus

Journal of gastroenterology and hepatology, 2020-12, Vol.35 (12), p.2210-2219

2020

Volltextzugriff (PDF)

Can we use old NAFLD data under the new MASLD definition?

Journal of hepatology, 2024-02, Vol.80 (2), p.e54-e56

2024

Volltextzugriff (PDF)

HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues

Journal of hepatology, 2019-03, Vol.70 (3), p.361-370

2019

Volltextzugriff (PDF)

Risk of liver‐related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease

Hepatology (Baltimore, Md.), 2022-11, Vol.76 (5), p.1409-1422

2022

Volltextzugriff (PDF)

Editorial: Can liver fat quantification stratify cardiovascular risk in type 2 diabetes?

Alimentary pharmacology & therapeutics, 2023-11, Vol.58 (10), p.1107-1108

2023

Volltextzugriff (PDF)

Association of genetic variations with NAFLD in lean individuals

Liver international, 2022-01, Vol.42 (1), p.149-160

2022

Volltextzugriff (PDF)

Secular trend of treatment uptake in patients with chronic hepatitis B: A territory‐wide study of 135 395 patients from 2000 to 2017

Journal of gastroenterology and hepatology, 2021-12, Vol.36 (12), p.3487-3499

2021

Volltextzugriff (PDF)

Thiazolidinediones reduce the risk of hepatocellular carcinoma and hepatic events in diabetic patients with chronic hepatitis B

Journal of viral hepatitis, 2020-09, Vol.27 (9), p.904-914

2020

Volltextzugriff (PDF)

Editorial: improvement of cardiovascular risk factor control in patients with type 2 diabetes and nonalcoholic fatty liver disease—time for action! Authors' reply

Alimentary pharmacology & therapeutics, 2023-05, Vol.57 (10), p.1172-1173

2023

Volltextzugriff (PDF)

1 – 25 von 306

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(286)
Mit Volltextzugriff
(294)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(19)

Menü

Weitere Dienste

Einstellungen

Distal femoral fractures

Current concepts in the diagnosis and management of extra-articular hip impingement syndromes

Surgical controversies and current concepts in Lisfranc injuries

A propofol binding site on mammalian GABAA receptors identified by photolabeling

Infant Feeding Practices in a Multi-Ethnic Asian Cohort: The GUSTO Study

Locating Binding Sites of the General Anaesthetic Propofol Using Photoaffinity Labelling

Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles

An Aging Population of Chronic Hepatitis B With Increasing Comorbidities: A Territory‐Wide Study From 2000 to 2017

Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatment

Angiotensin‐converting enzyme inhibitors prevent liver‐related events in nonalcoholic fatty liver disease

Geographical similarity and differences in the burden and genetic predisposition of NAFLD

Liver stiffness measurement predicts long‐term survival and complications in non‐alcoholic fatty liver disease

Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection

The safety of stopping nucleos(t)ide analogue treatment in patients with HBeAg‐negative chronic hepatitis B

Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B? Authors’ reply

Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patients

Elevated testosterone increases risk of hepatocellular carcinoma in men with chronic hepatitis B and diabetes mellitus

Can we use old NAFLD data under the new MASLD definition?

HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues

Risk of liver‐related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease

Editorial: Can liver fat quantification stratify cardiovascular risk in type 2 diabetes?

Association of genetic variations with NAFLD in lean individuals

Secular trend of treatment uptake in patients with chronic hepatitis B: A territory‐wide study of 135 395 patients from 2000 to 2017

Thiazolidinediones reduce the risk of hepatocellular carcinoma and hepatic events in diabetic patients with chronic hepatitis B

Editorial: improvement of cardiovascular risk factor control in patients with type 2 diabetes and nonalcoholic fatty liver disease—time for action! Authors' reply

Aktive Filter

Suchergebnisse filtern